YUMAB Identifies Promising Candidate for COVID-19 Antibody Therapy
- Tuesday, May 12, 2020, 7:14
- Environment
- Add a comment
BRAUNSCHWEIG, Germany, May 12, 2020 /PRNewswire/ — YUMAB, a German antibody development company, announced today it has identified fully human monoclonal antibodies with neutralizing activity against patient-derived coronavirus strain SARS-CoV2. This milestone was achieved in…
About the Author
adminasapcorp has written 41555 stories on this site.